Cardiol Therapeutics CRDL
NASDAQ CRDL
$1.12 -0.03 (-2.61%)
At close: Oct 23, 2026 · 4:00 PM EDT

Cardiol Therapeutics (CRDL) Return on Equity [ROE] (2021 - 2026)

Updated

Cardiol Therapeutics (CRDL) recorded Return on Equity [ROE] of -145.44% in Q2 2026, up 126.56 percentage points from -272.00% a year earlier and up 20.52 percentage points from the prior quarter.

Analysis

Cardiol Therapeutics (CRDL) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Cardiol Therapeutics reported Return on Equity [ROE] of -156.88%, down 18.83 percentage points from FY2024.

  • Annual Return on Equity [ROE] has declined for three straight years, with a four-year change of -85.51 percentage points (FY2021 to FY2025).
  • Across earlier years, Return on Equity [ROE] came in at -138.05% in FY2024 (-68.26 pp), -69.80% in FY2023 (-23.90 pp), -45.90% in FY2022 (+25.48 pp) and -71.38% in FY2021.
  • The Q2 2026 figure is the highest quarterly Return on Equity [ROE] since Q1 2024.
  • On a year-over-year basis, Return on Equity [ROE] rose in two of the last eight quarters, with an average year-over-year change of -53.46 percentage points.
  • Peak year-over-year performance for Return on Equity [ROE] in the last five years was a gain of 126.56 percentage points in Q2 2026, against a drop of 210.44 percentage points in Q3 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at -165.96% (Q1 2026), -243.36% (Q4 2025) and -327.76% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 19.33%
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn -
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.21%
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 31.52%
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 21.39%
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 83.75%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -18.38%
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 4.97%
10 Cardiol Therapeutics 96.99 Mn 34.78 Mn - -148.54%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -148.54%
Mar 31, 2026 -166.16%
Dec 31, 2025 -241.43%
Jun 30, 2024 -171.23%
Mar 31, 2024 -117.00%
Dec 31, 2023 -31.41%
Sep 30, 2023 -19.24%
Jun 30, 2023 -23.36%
Mar 31, 2023 -38.67%
Dec 31, 2022 -42.30%
Sep 30, 2022 -44.77%
Jun 30, 2022 -63.66%
Mar 31, 2022 -54.29%
Dec 31, 2021 -47.14%
Sep 30, 2021 -39.73%
Jun 30, 2021 -36.23%
API Access

Cardiol Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=CRDL&period=max&api_key=YOUR_API_KEY